STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Optex Systems Holdings Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Optex Systems (OPXS) reported an insider transaction: a director and 10% owner acquired 4,000 shares of common stock on November 4, 2025 at $16.74 per share. Following the transaction, the reporting person beneficially owned 51,600 shares directly, plus 786,006 shares indirectly through Sudbury Capital Fund, LP, and 25,000 shares indirectly via a SEP‑IRA. The filing notes the award vests 100% on January 1, 2027, and that the NASDAQ closing price on the grant date was $16.74.

Positive
  • None.
Negative
  • None.

Insights

Routine Form 4 showing a 4,000-share equity grant at $16.74.

The report lists an acquisition of 4,000 OPXS common shares at $16.74 on November 4, 2025, with a footnote that the award vests 100% on January 1, 2027. This structure is consistent with equity compensation rather than open‑market buying.

Post‑transaction holdings are detailed: 51,600 direct shares, plus 786,006 indirect via Sudbury Capital Fund, LP, and 25,000 indirect via a SEP‑IRA. As a disclosure of insider ownership and a single equity grant, the filing is typically neutral for valuation; actual impact depends on future activity and company performance.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dayton Judd

(Last) (First) (Middle)
1420 PRESIDENTIAL DRIVE

(Street)
RICHARDSON TX 75081

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Optex Systems Holdings Inc [ OPXS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
COMMON STOCK 11/04/2025 A 4,000(1) A $16.74(1) 51,600 D
COMMON STOCK 786,006 I By Sudbury Capital Fund, LP
COMMON STOCK 25,000 I By SEP-IRA
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. 100% vesting on January 1, 2027. The NASDAQ closing price per share of common stock on the date of grant was $16.74.
/s/ Roland S. Chase as attorney in fact for Dayton Judd 11/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did OPXS report on this Form 4?

A director and 10% owner acquired 4,000 shares of common stock on November 4, 2025 at $16.74 per share.

What are the reporting person’s OPXS holdings after the transaction?

Beneficial ownership includes 51,600 shares directly, 786,006 indirectly via Sudbury Capital Fund, LP, and 25,000 via a SEP‑IRA.

What is the vesting schedule for the reported OPXS shares?

The filing states 100% vesting on January 1, 2027.

What price is associated with the OPXS share acquisition?

The filing lists $16.74 per share, which matches the NASDAQ closing price on the grant date.

What roles does the reporting person have at OPXS?

The reporting person is disclosed as a Director and a 10% Owner.

When is the earliest transaction date shown in the OPXS Form 4?

The earliest transaction date reported is November 4, 2025.
Optex Systems

NASDAQ:OPXS

OPXS Rankings

OPXS Latest News

OPXS Latest SEC Filings

OPXS Stock Data

117.67M
5.35M
22.66%
35.54%
0.11%
Aerospace & Defense
Optical Instruments & Lenses
Link
United States
RICHARDSON